News
Company news and developments, with original sources and dates.
Updated from source
Funding RSS ↗2 briefsClear filters
News
Superluminal Medicines raises USD 60 million in Series B financing
On 2026-09-03, according to Xiniu Data, Superluminal Medicines completed Series B financing, raising USD 60 million. Investors were lead investor BVF Partners, RA Capital Management, Perceptive Advisors, NVIDIA and others. The company is a provider of U.S. AI generation drugs services.
Sep 3, 2026Read brief →
News
Superluminal Medicines completes USD 120 million Series A financing
On 2024-9-9, according to Xiniu Data, Superluminal Medicines completed USD 120 million Series A financing
Sep 9, 2024Read brief →